Novartis
Global medicines company for developing and producing drugs.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.
Visit website: https://www.novartis.com/
Details last updated 25-Dec-2019
Novartis Creations
Luxturna (voretigene neparvovec)
Prescription gene therapy product for treatment of inherited retinal disease
People at Novartis
Stephen Cleaver
Head of informatics systems at Novartis Institutes for Biomedical Research in Cambridge.
Novartis News
Inherited blindness can now be cured with gene therapy
BBC - 29-Apr-2021
A breakthrough gene therapy restores eyesight in patients with rare eye disease
Read more...$95M raised by Taysha for clinical trials of four new gene therapies
FierceBiotech - 05-Aug-2020
Company has gathered support from investors to quickly lead therapies to clinic then market
Read more...Role of immune cells in reversal of aging process- A study in mice models
University of Bern - 06-Jul-2020
Manipulation of Eosinophils in belly fat to promote healthy aging
Read more...Adicet merges with resTorbio for CAR T-cell therapy pipeline funding
FierceBiotech - 30-Apr-2020
The deal moves company forward to initiating phase 1 trials in non-Hodgkin lymphoma next year
Read more...First gene therapy for a rare eye disease, now NHS-approved
BBC - 17-Feb-2020
This life-changing new gene therapy will halt sight loss and improve vision
Read more...Competitors in big pharma accused of conspiring to inflate generic drug prices
Independent - 12-May-2019
Inflated prices of more than 100 generic drugs by as much as 1000 per cent
Read more...We Need a Different Approach to Drug Discovery
Fortune - 12-Mar-2018
Discovery of new cardiovascular medicines at lowest point in decades. Need a more focused medici...
Read more...FDA Target Rogue Gene Therapy Clinics
New York Times - 16-Nov-2017
FDA issued new guidelines for expedited review of stem cell and gene therapies. Will crack down ...
Read more...IBM Watson to make breast cancer treatment recommendations
pharmaphorum - 06-Jun-2017
Lessons learnt may be applied by other oncologists in future
Read more...Is This the Anti-Aging Pill We’ve All Been Waiting For?
MIT Technology Review - 28-Mar-2017
Novartis sought to see whether giving low doses of everolimus to people over 65 increased their r...
Read more...Big data promise exponential change in healthcare
Financial Times - 29-Nov-2016
GlaxoSmithKline employs online technology and a data algorithm developed by F1’s elite McLaren Ap...
Read more...Are Consumers and Doctors Finally Bridging the mHealth Gap?
mHealth Intelligence - 16-Jan-2016
Review of CES 2016 – consumer-focused conference is seeing more digital health each year. Volume...
Read more...Everyday drugs could give extra years of life
New Scientist - 01-Oct-2014
Rapamycin in mice The study was published in the Diabetes, Obesity and Metabolism journal.
Read more...
